Mobile Investor

 Stock Information
CLDX (NASDAQ)
Last Price: 2.92
Last Trade: 4:00 PM ET - Oct 20, 2017
Change: 0.05 down  (1.68%)
Open: 3.00
Close: 2.97
High: 3.00
Low: 2.88
52-Week High: 5.02
52-Week Low: 2.20
Volume: 715,532
Stock price graph
 Recent News
Oct 3, 2017
Celldex Therapeutics Appoints Margo Heath-Chiozzi, M.D., as Senior Vice President, Regulatory Affairs
Sep 22, 2017
Celldex Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 12, 2017
Celldex Announces Departure of Chief Medical Officer
Aug 23, 2017
Celldex Announces Completion of Enrollment in Phase 2b Study of Glembatumumab Vedotin in Triple Negative Breast Cancer
Aug 8, 2017
Celldex Reports Second Quarter 2017 Results
 Events & Presentations
Mar 4, 2015 - 8:40 AM ET
Cowen and Company 35th Annual Health Care Conference
Feb 24, 2015 - 8:00 AM ET
Celldex Therapeutics 2014 Year End Financial Results
Feb 12, 2015 - 10:20 AM ET
2015 Leerink Global Healthcare Conference
Nov 4, 2014 - 4:00 PM
Celldex Therapeutics Third Quarter Business and Financial Highlights Press Release Issued
Sep 8, 2014 - 1:25 PM ET
Morgan Stanley Healthcare Conference
 Financial Filings
Aug 8, 2017
Form 10-Q - Celldex Therapeutics, Inc.
May 9, 2017
Form 10-Q - Celldex Therapeutics, Inc.
Apr 28, 2017
Form DEF 14A - Celldex Therapeutics, Inc.
Apr 17, 2017
Form PRE 14A - Celldex Therapeutics, Inc.
Mar 14, 2017
Form 10-K - Celldex Therapeutics, Inc.
Nov 7, 2016
Form 10-Q - Celldex Therapeutics, Inc.
This is an optimized Investor Page for viewing on your mobile devices. To view our entire Investor Relations site, click here.
© 2017 Celldex Therapeutics, Inc.